Literature DB >> 22418277

FMCSA's medical review board: five years of progress in commercial driver medical examinations.

Kurt T Hegmann1, Gunnar B J Andersson, Michael I Greenberg, Barbara Phillips, Matthew Rizzo.   

Abstract

OBJECTIVE: To revise and update guidance recommendations to the Federal Motor Carrier Safety Administration for evaluating commercial drivers.
METHODS: The Federal Motor Carrier Safety Administration's medical review board has addressed guidance for commercial drivers for the past 5 years. The processes for most topics involve comprehensive literature searches, evidence reports, medical expert panel reports, critique of the literature, testimony, and decision making.
RESULTS: No quality literature evaluating risk of crash among commercial motor vehicle drivers was found for most medical conditions. Little literature was available for crash risk among all drivers. For select conditions, such as seizure disorders, obstructive sleep apnea, and narcolepsy, there is evidence of increased crash risk among the general driving population and evidence-based guidance is now available.
CONCLUSIONS: Detailed guidance from the Medical Review Board is available for assessing commercial drivers with various disorders. Many challenges remain.

Entities:  

Mesh:

Year:  2012        PMID: 22418277     DOI: 10.1097/JOM.0b013e3182480535

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  9 in total

1.  Quality measures for the care of patients with narcolepsy.

Authors:  Lois E Krahn; Shelley Hershner; Lauren D Loeding; Kiran P Maski; Daniel I Rifkin; Bernardo Selim; Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

2.  Multiple Conditions Increase Preventable Crash Risks Among Truck Drivers in a Cohort Study.

Authors:  Matthew S Thiese; Richard J Hanowski; Stefanos N Kales; Richard J Porter; Gary Moffitt; Nan Hu; Kurt T Hegmann
Journal:  J Occup Environ Med       Date:  2017-02       Impact factor: 2.162

Review 3.  Commercial Motor Vehicle Driver Obstructive Sleep Apnea Screening and Treatment in the United States: An Update and Recommendation Overview.

Authors:  Loretta J Colvin; Nancy A Collop
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

4.  Factors Associated with Colorectal Cancer Prevalence Among Long-Haul Truck Drivers in the United States.

Authors:  Charles R Rogers; Folasade P May; Ethan Petersen; Ellen Brooks; Jasmine A Lopez; Carson D Kennedy; Matthew S Thiese
Journal:  Am J Health Promot       Date:  2022-04-11

5.  Narcolepsy: let the patient's voice awaken us!

Authors:  Julie Flygare; Sairam Parthasarathy
Journal:  Am J Med       Date:  2014-06-12       Impact factor: 4.965

6.  Commercial Driver Medical Examinations: Prevalence of Obesity, Comorbidities, and Certification Outcomes.

Authors:  Matthew S Thiese; Gary Moffitt; Richard J Hanowski; Stefanos N Kales; Richard J Porter; Kurt T Hegmann
Journal:  J Occup Environ Med       Date:  2015-06       Impact factor: 2.162

Review 7.  Health assessment of commercial drivers: a meta-narrative systematic review.

Authors:  Abd Moain Abu Dabrh; Belal Firwana; Clayton T Cowl; Lawrence W Steinkraus; Larry J Prokop; Mohammad Hassan Murad
Journal:  BMJ Open       Date:  2014-03-06       Impact factor: 2.692

Review 8.  Sleep and Mental Health in Truck Drivers: Descriptive Review of the Current Evidence and Proposal of Strategies for Primary Prevention.

Authors:  Sergio Garbarino; Ottavia Guglielmi; Walter G Sannita; Nicola Magnavita; Paola Lanteri
Journal:  Int J Environ Res Public Health       Date:  2018-08-27       Impact factor: 3.390

9.  The Pre-Registry Commercial Driver Medical Examination: Screening Sensitivity and Certification Lengths for Two Safety-Related Medical Conditions.

Authors:  Stephen Vincent Burks; Jon Eugene Anderson; Bibhudutta Panda; Humza Syed Haider; Rebecca Haider; Dongnan Shi; Yutao Li; Michael Cagle; Denis Ostroushko; Zhining Sun; John Zaharick; Jeffrey Hickman; Erin Mabry; Mark Berger; Charles Czeisler; Stefanos Nikolaos Kales
Journal:  J Occup Environ Med       Date:  2020-03       Impact factor: 2.306

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.